Cargando…
Fragile X syndrome: a pilot proton magnetic resonance spectroscopy study in premutation carriers
PURPOSE: There is increasing evidence that neurodevelopmental differences in people with Fragile X syndrome (FraX) may be explained by differences in glutamatergic metabolism. Premutation carriers of FraX were originally considered to be unaffected although several recent reports demonstrate neuroan...
Autores principales: | Hallahan, Brian P, Daly, Eileen M, Simmons, Andrew, Moore, Caroline J, Murphy, Kieran C, Murphy, Declan D G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443443/ https://www.ncbi.nlm.nih.gov/pubmed/22958351 http://dx.doi.org/10.1186/1866-1955-4-23 |
Ejemplares similares
-
Genomic studies in fragile X premutation carriers
por: Lozano, Reymundo, et al.
Publicado: (2014) -
Fragile X Premutation
por: Tassone, Flora, et al.
Publicado: (2014) -
Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2022) -
X-inactivation in the clinical phenotype of fragile X premutation carrier sisters
por: Hall, Deborah A., et al.
Publicado: (2016) -
Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers
por: Polussa, Jonathan, et al.
Publicado: (2014)